BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nattiv R, Wojcicki JM, Garnett EA, Gupta N, Heyman MB. High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice. World J Gastroenterol 2012; 18(11): 1229-1234 [PMID: 22468086 DOI: 10.3748/wjg.v18.i11.1229]
URL: https://www.wjgnet.com/1007-9327/full/v18/i11/1229.htm
Number Citing Articles
1
Shomron Ben-Horin, Yehuda Chowers. Tailoring anti-TNF therapy in IBD: drug levels and disease activityNature Reviews Gastroenterology & Hepatology 2014; 11(4): 243 doi: 10.1038/nrgastro.2013.253
2
N. S. Ding, A. Hart, P. De Cruz. Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical managementAlimentary Pharmacology & Therapeutics 2016; 43(1): 30 doi: 10.1111/apt.13445
3
Jiri Bronsky, Lissy de Ridder, Frank M. Ruemmele, Anne Griffiths, Stephan Buderus, Ondrej Hradsky, Almuthe Christina Hauer. Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice SurveyJournal of Pediatric Gastroenterology & Nutrition 2019; 68(5): 676 doi: 10.1097/MPG.0000000000002233
4
Steffen Dan-Nielsen, Vibeke Wewer, Anders Paerregaard, Lars F. Hansen, Rasmus G. Nielsen, Aksel Lange, Christian Jakobsen. Does Infliximab Prevent Colectomy in Acute and Chronic Active Ulcerative Colitis?Journal of Pediatric Gastroenterology & Nutrition 2014; 58(6): 768 doi: 10.1097/MPG.0000000000000340
5
Ruben J. Colman, Jasbir Dhaliwal, Michael J. Rosen. Predicting Therapeutic Response in Pediatric Ulcerative Colitis—A Journey Towards Precision MedicineFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.634739
6
H.-I. Huppertz, H.W. Lehmann. Evidenz der Therapie chronisch-entzündlicher Erkrankungen in Kindheit und Adoleszenz mit BiologikaZeitschrift für Rheumatologie 2014; 73(10): 907 doi: 10.1007/s00393-014-1398-8
7
Logan Jerger, Jeffrey S. Hyams. Special considerations for biologic medications in pediatric ulcerative colitisExpert Opinion on Biological Therapy 2020; 20(4): 429 doi: 10.1080/14712598.2020.1685492
8
Marina Aloi, Federica Nuti, Laura Stronati, Salvatore Cucchiara. Advances in the medical management of paediatric IBDNature Reviews Gastroenterology & Hepatology 2014; 11(2): 99 doi: 10.1038/nrgastro.2013.158
9
Konstantinos Papamichael, Ann Gils, Paul Rutgeerts, Barrett G. Levesque, Séverine Vermeire, William J. Sandborn, Niels Vande Casteele. Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBDInflammatory Bowel Diseases 2015; 21(1): 182 doi: 10.1097/MIB.0000000000000202
10
Bethany R. Sharpless, Fernando del Rosario, Zarela Molle-Rios, Elora Hilmas. Use of Electronic Health Record Tools to Facilitate and Audit Infliximab PrescribingThe Journal of Pediatric Pharmacology and Therapeutics 2018; 23(1): 18 doi: 10.5863/1551-6776-23.1.18